Operating Lease, Right-of-Use Asset in USD of Mereo BioPharma Group plc from Q4 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Mereo BioPharma Group plc quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2022 to Q3 2025.
  • Mereo BioPharma Group plc Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $378K, a 58.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Mereo BioPharma Group plc Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $378K -$531K -58.4% 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 $522K -$463K -47% 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 $622K -$487K -43.9% 31 Mar 2025 10-Q 13 May 2025
Q4 2024 $727K -$518K -41.6% 31 Dec 2024 10-Q 10 Nov 2025
Q3 2024 $909K 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 $985K 30 Jun 2024 10-Q 13 Aug 2024
Q1 2024 $1.11M 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $1.25M -$420K -25.2% 31 Dec 2023 10-K 26 Mar 2025
Q4 2022 $1.67M 31 Dec 2022 10-K 27 Mar 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.